Equity Capital Markets
ImmunityBio
12/24
|
$100.0 Million
Âé¶¹´«Ã½ served as bookrunner for ImmunityBio, Inc. on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma